¿Es posible crear la adecuada sensación de riesgo entre los consumidores de cannabis medicinal?

Jose Antonio Ramos Atance, Francisco Arias Horcajadas


Es cada vez mayor el número de investigaciones relacionadas con las posibles aplicaciones terapéuticas de los cannabinoides. Aunque en algunas enfermedades los resultados obtenidos son esperanzadores, la investigación en desarrollo está en sus etapas iniciales. Para algunos síntomas se ha probado la efectividad medicinal de los cannabinoides. Pero, en muchos casos no se dispone todavía de la adecuada evidencia al respecto, ni son suficientes los datos existentes sobre los riesgos asociados al consumo de cannabis medicinal.

Palabras clave

Cannabis; uso medicinal; efectos adversos.

Texto completo:

PDF PDF (English)


Allan, G. M., Ramji, J., Perry, D., Ton, J., Beahm, N. P., Crisp, N.,… Lindblad, A. J. (2018). Simplified guideline for prescribing medical cannabinoids in primary care. Canadian Family Physician, 64, 111-120. PMID: 29449241.

Bonn-Miller, M. O., Pollack, C. V. Jr., Casarett, D., Dart, R., ElSohly, M., Good, L.,… Abrams, D. (2019). Priority considerations for medicinal cannabis-related research. Cannabis and Cannabinoid Research4, 139–157. doi:10.1089/can.2019.0045.

Borrás, R. (2019). Prospecto del cannabis para uso terapéutico. Colegio de Farmacéuticos de Barcelona. Retrieved at https://www.farmaceuticonline.com/es/cannabis/.

Cash, M. C., Cunnane, K., Fan, C. & Romero-Sandoval, E. A. (2020). Mapping cannabis potency in medical and recreational programs in the United States. PloS One, 15. doi:10.1371/journal.pone.0230167.

Cerdá, M., Mauro, C., Hamilton, A., Levy, N., Santaella-Tenorio, J., Hasin, D.,... Martins, S. (2020). Association between recreational marijuana legalization in the United States and changes in marijuana use and cannabis use disorder from 2008 to 2016. JAMA Psychiatry77, 165-171. doi:10.1001/jamapsychiatry.2019.3254.

D’Amico, E. J., Miles, J. N. & Tucker, J. S. (2015). Gateway to curiosity: Medical marijuana ads and intention and use during middle school. Psychology of Addictive Behaviors, 29, 613–619. doi:10.1037/adb0000094.

European Monitoring Centre for Drugs and Drug Addiction. (2018). Medical use of cannabis and cannabinoids: Questions and answers for policymaking. Luxemburgo: Publications Office of the European Union. doi:10.2810/979004.

Hasin, D. S., Sarvet, A. L., Cerdá, M., Keyes, K. M., Stohl, M., Galea, S. & Wall, M. M. (2017). US adult illicit cannabis use, cannabis use disorder, and medical marijuana laws: 1991-1992 to 2012-2013. JAMA Psychiatry, 74, 579-588. doi:10.1001/jamapsychiatry.2017.0724.

Health Canada. (2018). Information for health care professionals. Cannabis

(marihuana, marijuana) and the cannabinoids. Dried or fresh plant and oil administration by ingestion or other means. Otawa: Canadian Ministry of Health. Government of Canada. Retrieved at https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-medication/cannabis/information-medical-practitioners/information-health-care-professionals-cannabis-cannabinoids-eng.pdf.

Isorna, M., Pascual, F., Aso, E. & Arias, F. (2022). Impacto de la legalización del consumo recreativo del cannabis. Adicciones. Advance publication online. doi:10.20882/adicciones.1694.

Lancaster, K., Seear, K. & Ritter, A. (2017). Making medicine; producing pleasure: A critical examination of medicinal cannabis policy and law in Victoria, Australia. International Journal of Drug Policy, 49, 117-125. doi:10.1016/j.drugpo.2017.07.020.

Mair, C., Sumetsky, N., Kranich, C. & Freisthler, B. (2021). Availability of medical cannabis dispensaries and cannabis abuse/dependence-related hospitalizations in California. Addiction116, 1908-1913. doi:10.1111/add.15420.

Melchior, M., Nakamura, A., Bolze, C., Hausfater, F., El Khoury, F., Mary-Krause, M. & Da Silva, M. A. (2019). Does liberalisation of cannabis policy influence levels of use in adolescents and young adults? A systematic review and meta-analysis. BMJ Open, 9. doi:10.1136/bmjopen-2018-025880.

Mücke, M., Phillips, T., Radbruch, L., Petzke, F. & Häuser, W. (2018). Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev, 3. CD012182. doi:10.1002/14651858.CD012182.pub2.

National Academies of Sciences, Engineering, and Medicine. (2017). The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press. doi:10.17226/24625.

Pergam, S. A., Woodfield, M. C., Lee, C. M., Cheng, G. S., Baker, K. K., Marquis, S. R. & Fann, J. R. (2017). Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer, 123, 4488-4497. doi:10.1002/cncr.30879.

Smart, R. & Pacula, R. L. (2019). Early evidence of the impact of cannabis legalization on cannabis use, cannabis use disorder, and the use of other substances: Findings from state policy evaluations. The American Journal of Drug and Alcohol Abuse, 45, 644-663. doi:10.1080/00952990.2019.1669626.

Steigerwald, S., Cohen, B. E., Vali, M., Hasin, D., Cerda, M. & Keyhani, S. (2020). Differences in opinions about marijuana use and prevalence of use by state legalization status. Journal of Addiction Medicine, 14, 337. doi:10.1097/ADM.0000000000000593.

Wang, G. S., Hall, K., Vigil, D., Banerji, S., Monte, A. & VanDyke, M. (2017). Marijuana and acute health care contacts in Colorado. Preventive Medicine, 104, 24-30. doi:10.1016/j.ypmed.2017.03.022.

Wang, G., Davies, S., Halmo, L., Sass, A. & Mistry, R. (2018). Impact of marijuana legalization in Colorado on adolescent emergency and urgent care visits. Journal of Adolescent Health, 63, 239-241. doi:10.1016/j.jadohealth.2017.12.010.

Whitehill, J. M., Harrington, C., Lang, C. J., Chary, M., Bhutta, W. A. & Burns, M. M. (2019). Incidence of pediatric cannabis exposure among children and teenagers aged 0 to 19 years before and after medical marijuana legalization in Massachusetts. JAMA Network Open, 2. doi:10.1001/jamanetworkopen.2019.9456.

Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V.,… Kleijnen, J. (2015). Cannabinoids for medical use: A systematic review and meta-analysis. Journal of American Medical Association, 313, 2456–2473. doi:10.1001/jama.2015.6358.

Wolf, L. A., Perhats, C., Clark, P. R., Frankenberger, W. D. & Moon, M. D. (2020). The perceived impact of legalized cannabis on nursing workload in adult and pediatric emergency department visits: A qualitative exploratory study. Public Health Nursing, 37, 5-15. doi:10.1111/phn.12653.

Zinboonyahgoon, N., Srisuma, S., Limsawart, W., Rice, A. S. C. & Suthisisang, C. (2021). Medicinal cannabis in Thailand: 1-year experience after legalization. Pain, 162

(Suppl. 1), 105-109. doi:10.1097/j.pain.0000000000001936.

DOI: https://doi.org/10.20882/adicciones.1656

Enlaces refback

  • No hay ningún enlace refback.